Used in the synthesis of biologically active compounds, particularly in pharmaceutical research targeting enzyme inhibitors. Its structural features, including the bromo-pyridine and dichloroacetamide moieties, make it a valuable intermediate in developing potential therapeutic agents, especially for oncology and inflammatory diseases. The fluoromethyl and hydroxyethyl groups enhance metabolic stability and binding selectivity in drug design. Commonly employed in medicinal chemistry for structure-activity relationship (SAR) studies.